Agenus

NCT00081809

A Safety and Effectiveness Study of Vaccine Therapy in Patients With Indolent Lymphoma

NCT00082459

Trial to Compare the Routes of Administration of an Investigational, Personalized, Therapeutic Cancer Vaccine Oncophage (HSPPC-96) in Patients With Metastatic Renal Cell Carcinoma

NCT00058747

AG-858 in Patients Who Are Cytogenetically Positive After Treatment With Gleevec™

NCT00098085

Study of the Feasibility to Derive Vaccine From Tumor Tissue in Patients With Non-Small Cell Lung Cancer

NCT00905060

HSPPC-96 Vaccine With Temozolomide in Patients With Newly Diagnosed GBM

NCT01147536

Study of Vitespen (HSPPC-96, Oncophage ®) for Immune Response Assessment in Participants With Resectable Renal Cell Carcinoma at Intermediate Risk of Recurrence

NCT01687595

Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Participants With Recurrent Genital Herpes

NCT01814813

Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery

NCT03411473

Study of AGEN1884 With Pembrolizumab in 1L NSCLC

NCT03894215

RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer

NCT04028063

Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas

NCT04607200

AGEN2034 & AGEN1884 in Patients With Recurrent, Inoperable Angiosarcoma

NCT05033132

A Phase II Study of Balstilimab Independently or in Combination With Zalifrelimab in Advanced Cervical Cancer

NCT05608044

A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer

NCT05529316

A Study of Botensilimab (AGEN1181) for the Treatment of Advanced Melanoma

NCT05571293

Combination Immunotherapy in Colorectal Cancer

NCT05630183

A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer

NCT05891821

Assessment of the Safety and Efficacy of Balstilimab for the Treatment of Relapsed/Refractory Lymphomas (IMMONC0001)

NCT05928806

Advanced Renal Cell Cancer Combination ImmunoThErapy Clinical Trial

NCT05363709

BALSTILIMAB on Viral Clearance in HPV+ Oropharyngeal Cancer Patients

NCT05561491

A Study of ONCOS-102 in Combination With Other Novel Immune-therapies in Advanced Treatment-resistant Melanoma Patients

NCT05864534

Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma

NCT06300463

Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases

NCT06322108

Assessment of the Safety and Efficacy of Balstilimab in Combination With Botensilimab for the Treatment of Non-Small Cell Lung Cancer (IMMONC0008)

NCT05632328

AGEN1423 and Botensilimab w/ or w/o Chemo in PDAC

NCT06268015

Botensilimab and Balstilimab Optimization in Colorectal Cancer

NCT06843434

A Study of Botensilimab and Balstilimab for Rectal Adenocarcinoma

NCT06843551

"The Miami EMPIRE Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation"